News from Veracyte A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 15, 2017, 08:00 ET Veracyte to Host Conference Call and Webcast to Discuss Fourth Quarter and Full-Year 2016 Financial Results on Wednesday, March 1, 2017

Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its fourth quarter and full-year 2016 financial results after close of market on...


Feb 08, 2017, 08:00 ET Veracyte to Expand Patient Access to the Afirma® Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement with Quest Diagnostics

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Feb 06, 2017, 08:00 ET Veracyte Announces Final Medicare Coverage Policies for Percepta® Bronchial Genomic Classifier

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing unnecessary surgeries and healthcare costs by resolving diagnostic...


Feb 02, 2017, 08:00 ET Veracyte to Present at LEERINK Partners 6th Annual Global Healthcare Conference

Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, chairman of the board, president and chief executive officer, will present...


Dec 13, 2016, 08:00 ET Veracyte Announces Appointment of Kevin K. Gordon and Other Changes to Its Board of Directors

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


Nov 22, 2016, 07:00 ET Veracyte Announces that CMS Will Maintain Historic Medicare Reimbursement Rate for the Afirma® Gene Expression Classifier in 2017

Veracyte, Inc. (NASDAQ: VCYT) announced today that the Centers for Medicare and Medicaid Services (CMS) has released its revised final 2017...


Nov 21, 2016, 08:00 ET Veracyte Appoints Keith Kennedy as Chief Financial Officer

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


Nov 15, 2016, 08:00 ET Veracyte to Participate in Two Upcoming Investor Conferences

Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will participate in a fireside chat...


Nov 03, 2016, 16:05 ET Veracyte Announces Third Quarter 2016 Financial Results

Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the third quarter ended September 30, 2016 and provided an update on recent...


Nov 02, 2016, 08:00 ET Veracyte Announces Pricing of Public Offering of 5,000,000 Shares of Common Stock

Veracyte, Inc. (NASDAQ: VCYT) today announced the pricing of an underwritten public offering of 5,000,000 shares of its common stock at a public...


Nov 01, 2016, 16:12 ET Veracyte Announces Proposed Public Offering of Common Stock

Veracyte, Inc. (NASDAQ: VCYT) today announced that it has commenced an underwritten public offering of its common stock. All of the shares are...


Oct 26, 2016, 16:30 ET New Data Show that Use of Percepta® Bronchial Genomic Classifier Reduces Surgeries and Other Costly Procedures in Lung Cancer Screening and Diagnosis

Veracyte, Inc. (NASDAQ: VCYT) today announced new data from a prospective, multicenter clinical utility study showing that use of the...


Oct 25, 2016, 08:00 ET Veracyte Announces Launch of Envisia™ Genomic Classifier for Improved Diagnosis of Idiopathic Pulmonary Fibrosis at CHEST Annual Meeting 2016

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


Oct 17, 2016, 17:30 ET Veracyte Releases Preliminary Third Quarter 2016 Financial Results

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


Oct 13, 2016, 08:00 ET Data Demonstrating Clinical Value of Veracyte Genomic Tests for Use in Lung Cancer and IPF to Be Presented at CHEST Annual Meeting 2016

Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company that reduces unnecessary surgeries and healthcare costs by resolving diagnostic...


Sep 30, 2016, 19:00 ET Veracyte Releases Statement on CMS's Final 2017 Gapfill Rate for the Afirma® Gene Expression Classifier

 Veracyte, Inc. (NASDAQ: VCYT), a genomic diagnostics company focused on reducing diagnostic uncertainty, today issued the statement below...


Sep 23, 2016, 11:45 ET Veracyte Presents Data Demonstrating Potential to Enhance Afirma® Gene Expression Classifier Using an RNA Sequencing Platform

 Veracyte, Inc. (NASDAQ: VCYT) today announced new data suggesting the potential to enhance the performance of the Afirma Gene Expression...


Sep 15, 2016, 16:05 ET Veracyte Secures Draft Medicare Local Coverage Determination for Percepta® Bronchial Genomic Classifier from Palmetto GBA

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC), has posted a draft local...


Sep 15, 2016, 08:00 ET Veracyte Announces Data from Seven Afirma® Gene Expression Classifier Studies to Be Presented at the 86th Annual Meeting of the American Thyroid Association

 Veracyte, Inc. (NASDAQ: VCYT) today announced that external researchers will present six posters that reinforce the role of the Afirma...


Sep 08, 2016, 07:30 ET Veracyte Achieves Major Medicare Coverage Milestone for the Percepta® Classifier to Improve Lung Cancer Diagnosis

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Noridian Healthcare Solutions, the nation's largest Medicare Administrative Contractor...


Aug 30, 2016, 08:00 ET Veracyte to Present at Morgan Stanley Global Healthcare Conference

 Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie H. Anderson, president and chief executive officer, will present at the Morgan...


Aug 03, 2016, 16:05 ET Veracyte Announces Second Quarter 2016 Financial Results

Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the second quarter ended June 30, 2016 and provided an update on recent...


Jul 12, 2016, 08:00 ET Veracyte to Host Conference Call and Webcast to Discuss Second Quarter 2016 Financial Results on Wednesday, August 3, 2016

 Veracyte, Inc. (NASDAQ: VCYT) today announced that it will report its second quarter 2016 financial results after close of market on...


Jun 30, 2016, 08:00 ET Veracyte to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference

Veracyte, Inc. (NASDAQ: VCYT) today announced that Bonnie Anderson, president and chief executive officer, will present at the Cantor...


Jun 27, 2016, 07:30 ET Veracyte Named a San Francisco Bay Area 2016 "Top Workplace"

 Veracyte, Inc. (NASDAQ: VCYT), a molecular diagnostics company pioneering the field of molecular cytology, today announced that it has been...